ReviewMacromolecular rapid communications2026
Aliphatic Poly(Carbonate)s with Acid Responsive Release Mechanisms for Micellar Anti-Tumor Drug Delivery.
Review in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Micellar drug delivery systems have emerged as a versatile platform for improving the solubility, stability, and targeted release of chemo(immuno)therapeutics. This review focuses on micellar formulations that combine two key design principles: the inherent biodegradability of aliphatic poly(carbonate)s and the universal acid-responsive trigger mechanism. These systems are particularly attractive for tumor therapy, where the acidic microenvironment can be exploited for controlled drug release. We differentiate between two major classes: (i) systems employing acid-labile linkages for reversible conjugation of pharmaceutically active compounds, and (ii) systems in which micelle disassembly or polymer backbone degradation is governed by acid-responsive functionalities. Both categories are systematically evaluated according to the chemical motifs enabling acid sensitivity, including oximes, imines, hydrazones, boronate ester, acetals, ketals, and tertiary amines, among others. The review highlights recent advances in synthetic strategies, structure-property relationships, and therapeutic performance, emphasizing how these design elements synergistically enhance drug loading, release kinetics, and biocompatibility. Finally, we discuss current challenges and future directions for translating these smart micellar systems into promising tumor-targeted (immuno-)therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.